Find a Doctor
Yoshie Umemura, MD, is the Division Chief of Neuro-Oncology, the William R. and Joan R. Shapiro Chair for Neuro-Oncology Research, associate professor of neurology at Barrow Neurological Institute, and Chief Medical Officer at the Ivy Brain Tumor Center. She is board certified in neurology by the American Board of Psychiatry and Neurology, as well as neuro-oncology by the United Council for Neurologic Subspecialties.
Dr. Umemura’s expertise rests on the axis of brain tumors and cancers of the central nervous system, as well as the neurological complications from cancer. She is a member of the American Academy of Neurology, the American Society of Clinical Oncology, the International Primary CNS Lymphoma Collaborative Group, and the Society for Neuro-Oncology.
Dr. Umemura earned her medical degree from St. George’s University School of Medicine in Grenada. She completed her neurology residency at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire and her neuro-oncology fellowship at Memorial Sloan Kettering Cancer Center in New York City.
Dr. Umemura’s professional path has been forged by a focus on research projects that advance the care of, and quality of life in, patients with brain tumors. She’s deeply invested in translational brain tumor clinical research—specifically gliomas, glioblastoma, and central nervous system lymphomas—and hopes to have a hand in a variety of clinical trial developments and consortia moving forward.
For more information or to request an appointment with Dr. Umemura, please call (602) 406-2800.
- Aetna
- AHCCS (Referral Required)
- Blue Cross Blue Shield
- Blue Cross Blue Shield Third Party
- Cigna
- Commercial Networks
- Government Plans
- Humana
- Market Place Plans (Referral Required)
- Medicare Advantage Plans (Referral Required)
- United Healthcare
- MS, University of Michigan, Clinical Research Design and Statistical Analysis, 2021
- Fellowship, Memorial Sloan Kettering Cancer Center, Neuro-Oncology, 2015-2017
- Residency, Dartmouth Hitchcock Medical Center, Neurology, 2012-2015
- Internship, Brookdale University Hospital Medical Center, Internal Medicine, 2011-2012
- MD, St. George’s University, School of Medicine, 2011
- BS, University of California—Riverside, Biology, 2005
- American Academy of Neurology
- American Society of Clinical Oncology
- International Primary CNS Lymphoma Collaborative Group
- Society for Neuro-Oncology
GTP signaling links metabolism, DNA repair, and responses to genotoxic stress
Date: 04/2023
Authors: Weihua Zhou, Zitong Zhao, Angelica Lin, John Yang, Jie Xu, Wilder-Romans Kari, Annabel Yang, Jing Li, Sumeet Solanki, Jennifer Speth, Natalie Walker, Andrew J. Scott, Ayesha U. Kothari, Yangyang Yao, Erik R. Peterson, Navyateja Korimerla, Christian K. Werner, Jessica Liang, Janna Jacobson, Sravya Palavalasa, Alexandra M. Obrien, Ameer L. Elaimy, Sean P. Ferris, Shuang G. Zhao, Jann N. Sarkaria, Balázs Győrffy, Shuqun Zhang, Wajd N. Al-Holou, Yoshie Umemura, Meredith A. Morgan, Theodore S. Lawrence, Costas A. Lyssiotis
Metabolomic profiles of human glioma inform patient survival
Date: 02/2023
Authors: Andrew J. Scott, Luis O. Correa, Donna Edwards, Yilun Sun, Visweswaran Ravikumar, Anthony C. Andren, Li Zhang, Sudharsan Srinivasan, Neil Jairath, Kait Verbal, Karin Muraszko, Oren Sagher, Shannon A. Carty, Shawn Hervey-Jumper, Daniel Orringer, Michelle M. Kim, Larry Junck, Yoshie Umemura, Denise Leung, Sriram Venneti, Sandra Camelo-Piragua, Theodore S. Lawrence, Joseph E. Ippolito, Wajd N. Al-Holou, Prakash Chinnaiyan, Jason Heth, Arvind Rao, Costas A. Lyssiotis, Daniel R. Wahl
Efficacy and toxicity with radiation field designs and concurrent temozolomide for CNS lymphoma
Date: 12/2022
Authors: Anna M. Laucis, Katherine Selwa, Yilun Sun, Michelle M. Kim, Kyle C. Cuneo, Theodore S. Lawrence, Daniel R. Wahl, Larry Junck, Yoshie Umemura
Discordance Between Perceptions and Experience of Lumbar Puncture: A Prospective Study
Date: 10/2022
Authors: Yoshie Umemura, Baber Khan, Benjamin J. Weill, Justin J. Buthorn, Anna Skakodub, Andrew J. Ridder, Kathryn S. Nevel, Yilun Sun, Adrienne Boire
Liquid biopsy in gliomas: A RANO review and proposals for clinical applications
Date: 06/2022
Authors: Riccardo Soffietti, Chetan Bettegowda, Ingo K. Mellinghoff, Katherine E. Warren, Manmeet S. Ahluwalia, John F. De Groot, Evanthia Galanis, Mark R. Gilbert, Kurt A. Jaeckle, Emilie Le Rhun, Roberta Rudà, Joan Seoane, Niklas Thon, Yoshie Umemura, Michael Weller, Martin J. van den Bent, Michael A. Vogelbaum, Susan M. Chang, Patrick Y. Wen
- English
- (602) 406-2800
- Fax: (602) 406-2877
Yoshie Umemura, MD, is the Division Chief of Neuro-Oncology, the William R. and Joan R. Shapiro Chair for Neuro-Oncology Research, associate professor of neurology at Barrow Neurological Institute, and Chief Medical Officer at the Ivy Brain Tumor Center. She is board certified in neurology by the American Board of Psychiatry and Neurology, as well as neuro-oncology by the United Council for Neurologic Subspecialties.
Dr. Umemura’s expertise rests on the axis of brain tumors and cancers of the central nervous system, as well as the neurological complications from cancer. She is a member of the American Academy of Neurology, the American Society of Clinical Oncology, the International Primary CNS Lymphoma Collaborative Group, and the Society for Neuro-Oncology.
Dr. Umemura earned her medical degree from St. George’s University School of Medicine in Grenada. She completed her neurology residency at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire and her neuro-oncology fellowship at Memorial Sloan Kettering Cancer Center in New York City.
Dr. Umemura’s professional path has been forged by a focus on research projects that advance the care of, and quality of life in, patients with brain tumors. She’s deeply invested in translational brain tumor clinical research—specifically gliomas, glioblastoma, and central nervous system lymphomas—and hopes to have a hand in a variety of clinical trial developments and consortia moving forward.
For more information or to request an appointment with Dr. Umemura, please call (602) 406-2800.
- (602) 406-2800
- Fax: (602) 406-2877
- Aetna
- AHCCS (Referral Required)
- Blue Cross Blue Shield
- Blue Cross Blue Shield Third Party
- Cigna
- Commercial Networks
- Government Plans
- Humana
- Market Place Plans (Referral Required)
- Medicare Advantage Plans (Referral Required)
- United Healthcare
- MS, University of Michigan, Clinical Research Design and Statistical Analysis, 2021
- Fellowship, Memorial Sloan Kettering Cancer Center, Neuro-Oncology, 2015-2017
- Residency, Dartmouth Hitchcock Medical Center, Neurology, 2012-2015
- Internship, Brookdale University Hospital Medical Center, Internal Medicine, 2011-2012
- MD, St. George’s University, School of Medicine, 2011
- BS, University of California—Riverside, Biology, 2005
- American Academy of Neurology
- American Society of Clinical Oncology
- International Primary CNS Lymphoma Collaborative Group
- Society for Neuro-Oncology
GTP signaling links metabolism, DNA repair, and responses to genotoxic stress
Date: 04/2023
Authors: Weihua Zhou, Zitong Zhao, Angelica Lin, John Yang, Jie Xu, Wilder-Romans Kari, Annabel Yang, Jing Li, Sumeet Solanki, Jennifer Speth, Natalie Walker, Andrew J. Scott, Ayesha U. Kothari, Yangyang Yao, Erik R. Peterson, Navyateja Korimerla, Christian K. Werner, Jessica Liang, Janna Jacobson, Sravya Palavalasa, Alexandra M. Obrien, Ameer L. Elaimy, Sean P. Ferris, Shuang G. Zhao, Jann N. Sarkaria, Balázs Győrffy, Shuqun Zhang, Wajd N. Al-Holou, Yoshie Umemura, Meredith A. Morgan, Theodore S. Lawrence, Costas A. Lyssiotis
Metabolomic profiles of human glioma inform patient survival
Date: 02/2023
Authors: Andrew J. Scott, Luis O. Correa, Donna Edwards, Yilun Sun, Visweswaran Ravikumar, Anthony C. Andren, Li Zhang, Sudharsan Srinivasan, Neil Jairath, Kait Verbal, Karin Muraszko, Oren Sagher, Shannon A. Carty, Shawn Hervey-Jumper, Daniel Orringer, Michelle M. Kim, Larry Junck, Yoshie Umemura, Denise Leung, Sriram Venneti, Sandra Camelo-Piragua, Theodore S. Lawrence, Joseph E. Ippolito, Wajd N. Al-Holou, Prakash Chinnaiyan, Jason Heth, Arvind Rao, Costas A. Lyssiotis, Daniel R. Wahl
Efficacy and toxicity with radiation field designs and concurrent temozolomide for CNS lymphoma
Date: 12/2022
Authors: Anna M. Laucis, Katherine Selwa, Yilun Sun, Michelle M. Kim, Kyle C. Cuneo, Theodore S. Lawrence, Daniel R. Wahl, Larry Junck, Yoshie Umemura
Discordance Between Perceptions and Experience of Lumbar Puncture: A Prospective Study
Date: 10/2022
Authors: Yoshie Umemura, Baber Khan, Benjamin J. Weill, Justin J. Buthorn, Anna Skakodub, Andrew J. Ridder, Kathryn S. Nevel, Yilun Sun, Adrienne Boire
Liquid biopsy in gliomas: A RANO review and proposals for clinical applications
Date: 06/2022
Authors: Riccardo Soffietti, Chetan Bettegowda, Ingo K. Mellinghoff, Katherine E. Warren, Manmeet S. Ahluwalia, John F. De Groot, Evanthia Galanis, Mark R. Gilbert, Kurt A. Jaeckle, Emilie Le Rhun, Roberta Rudà, Joan Seoane, Niklas Thon, Yoshie Umemura, Michael Weller, Martin J. van den Bent, Michael A. Vogelbaum, Susan M. Chang, Patrick Y. Wen
- English